InvestorsHub Logo

moneycrew

02/14/21 9:37 AM

#146846 RE: misiu143 #146843

That is the problem , someone posted here in the past that BP paying about 40-45% of FDA bills .. how is that right , and what else could be expected..

If they gave us an EUA we'd pay 90 percent of their bills! Good business practice, no?

justdafactss

02/14/21 9:58 AM

#146852 RE: misiu143 #146843

Speaking of paying bills- Did Samsung get that $19M yet?

What about Fife- He get his $7.5M due him this month?

CYDY is clearly out of their league here and pretty sure they know it.

Seems they're quite comfortable on the OTC with no NASDAQ exchange hassles, no BLA paperwork hassles, and seemingly suppressing the CD12 results allows insiders to dump while the dumping is good.

Yep, all is just fine and dandy on the OTC where options/warrants can be exercised and salaries can be paid...no real work to do, just a good story to tell is all that is required...pretty sweet gig indeed.

Hookmeistr

02/14/21 11:32 AM

#146885 RE: misiu143 #146843

Misiu, I was trying to think of how best to respond to dadbrotheroftwins question about other countries stepping up if the FDA fails to approve. I know that I believe another country would but I wasn't sure how to effectively express it so I did not. Your response was, in my opinion, spot on correct.

1. Big problem, getting bigger with mutations.
2. Mortality a global concern and apparently getting bigger with mutations.
3. Leronlimab/Vyrologic's MOA becoming widely known and understood and gaining traction. This fact alone will begin to make it hard to ignore and the demand will become too great.
4. Safety is undeniable.
5. Efficacy soon to be proven via CD-12 results but already undeniable by many, especially the folks who have directly benefitted via EIND.

I'm not saying if the FDA doesn't approve that it won't slow us down but I don't believe for a minute that it will stop us. It would be just another hurdle that, in my opinion, will be successfully cleared. I have a feeling though that because of the aforementioned reasons, and probably more I haven't listed, that the FDA will find it hard to legitimately deny EUA and eventually full approval.

These are just my opinions.